Recursion Pharmaceuticals Inc (RXRX)

04:16 AM

RXRX (RXRX) insider details 50,000-share planned sale and recent stock trades - Stock Titan

04:16 AM

09:39 AM

RXRX|Recursion Pharmaceuticals Inc|Price:3.030| - TradingKey

09:39 AM

03:43 AM

Recursion Pharmaceuticals Inc (RXRX) Cash Flow - TradingKey

03:43 AM

01:51 AM

AI Stocks: Why Tempus AI (NASDAQ:TEM), Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrodinger (NASDAQ:SDGR) Are in Focus - Kalkine Media

01:51 AM

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

Recursion Pharmaceuticals Stock (RXRX) Opinions on Trading Ranges and Biotech Prospects - Quiver Quantitative

Jul 25, 2026

Jul 25, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 25, 2026

Jul 25, 2026

Recursion Pharmaceuticals Inc (RXRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 25, 2026

Jul 25, 2026

Recursion Pharmaceuticals, Inc (RXRX) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks

Jul 25, 2026

Jul 24, 2026

Recursion Pharmaceuticals Inc (RXRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 24, 2026

Jul 24, 2026

Recursion Pharmaceuticals Inc (RXRX) Institutional Confidence - TradingKey

Jul 24, 2026

Jul 24, 2026

RXRX|Recursion Pharmaceuticals Inc|Price:2.995|Chg%:-0.015 - TradingKey

Jul 24, 2026

Jul 24, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Options Chain - Yahoo! Finance Canada

Jul 24, 2026

Jul 24, 2026

Recursion Pharmaceuticals Inc (RXRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 24, 2026

Jul 23, 2026

Recursion Pharmaceuticals (RXRX) Proxy filing Summary - Quartr

Jul 23, 2026

Jul 23, 2026

Recursion Pharmaceuticals (RXRX) Guggenheim Securities 2nd Annual Healthcare Innovation Conference summary - Quartr

Jul 23, 2026

Jul 23, 2026

RXRX|Recursion Pharmaceuticals Inc|Price:3.030|Chg%:+0.020 - TradingKey

Jul 23, 2026

Jul 22, 2026

RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ - Stocktwits

Jul 22, 2026

Jul 21, 2026

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jul 21, 2026

Jul 21, 2026

Recursion Pharmaceuticals Stock Short Interest Falls to 34.41% - Quiver Quantitative

Jul 21, 2026

Jul 21, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 150% Upside Potential in Biotechnology - DirectorsTalk Interviews

Jul 21, 2026

Jul 20, 2026

RXRX: Recursion Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 20, 2026

Jul 20, 2026

Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance

Jul 20, 2026

Jul 17, 2026

Form 144 RECURSION PHARMACEUTICALS For: 17 July By Investing.com - Investing.com Canada

Jul 17, 2026

Jul 16, 2026

Form 144 RECURSION PHARMACEUTICALS For: 16 July By Investing.com - Investing.com Nigeria

Jul 16, 2026

Jul 16, 2026

RXRX Stock Slips Onto Watchlists After Insider Form 144 - timothysykes.com

Jul 16, 2026

Jul 16, 2026

RXRX Stock Under Pressure As Insider Signals Share Sale - StocksToTrade

Jul 16, 2026

Jul 14, 2026

Why Recursion Pharmaceuticals (RXRX) Outpaced the Stock Market Today - Yahoo Finance

Jul 14, 2026

Jul 14, 2026

Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? - The Globe and Mail

Jul 14, 2026

Jul 13, 2026

Form 144 RECURSION PHARMACEUTICALS For: 13 July By Investing.com - Investing.com Australia

Jul 13, 2026

Jul 13, 2026

Price to sales forward of Recursion Pharmaceuticals, Inc. – NASDAQ:RXRX - TradingView

Jul 13, 2026

Jul 13, 2026

Price to book forward of Recursion Pharmaceuticals, Inc. – NASDAQ:RXRX - TradingView

Jul 13, 2026

Jul 13, 2026

Enterprise value to revenue forward of Recursion Pharmaceuticals, Inc. – NASDAQ:RXRX - TradingView

Jul 13, 2026

Jul 13, 2026

Price to earnings forward of Recursion Pharmaceuticals, Inc. – NASDAQ:RXRX - TradingView

Jul 13, 2026

Jul 12, 2026

Recursion Pharmaceuticals (RXRX) Highlights Clinical Progress, Is The Stock Fully Priced? - Sahm

Jul 12, 2026

Jul 11, 2026

2 Beaten-Down Stocks That Still Aren't Worth Buying - The Motley Fool

Jul 11, 2026

Jul 11, 2026

2 Beaten-Down Stocks That Still Aren't Worth Buying - The Motley Fool

Jul 11, 2026

Jul 11, 2026

Recursion Pharmaceuticals Stock (RXRX) Opinions on Biotech AI Prospects - Moomoo

Jul 11, 2026

Jul 10, 2026

Form 144 RECURSION PHARMACEUTICALS For: 10 July By Investing.com - Investing.com South Africa

Jul 10, 2026

Jul 10, 2026

Recursion Pharmaceuticals (RXRX) Goldman Sachs 46th Annual Global Healthcare Conference 2025 summary - Quartr

Jul 10, 2026

Jul 09, 2026

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake - Moomoo

Jul 09, 2026

Jul 09, 2026

Insider Sell: Blake Borgeson Sells 40,000 Shares of Recursion Ph - GuruFocus

Jul 09, 2026

Jul 09, 2026

Form 4 Recursion Pharmaceuticals Inc For: 9 July By Investing.com - Investing.com South Africa

Jul 09, 2026

Jul 09, 2026

Recursion Pharmaceuticals director Borgeson sells $158,500 stock By Investing.com - Investing.com Nigeria

Jul 09, 2026

Jul 09, 2026

Recursion Pharmaceuticals director Borgeson sells $158,500 stock - Investing.com

Jul 09, 2026

Jul 09, 2026

Recursion Pharmaceuticals (RXRX) director sells 40,000 shares in 10b5-1 trade - Stock Titan

Jul 09, 2026